Dexmedetomidine vs midazolam for preterm babies on a ventilator
Treatments studied
Part of Lungs & breathing clinical trials.
This study compares two sedative medicines, dexmedetomidine and midazolam, to see which one helps preterm babies on a ventilator breathe on their own sooner. Your baby may be eligible if they were born very early and need medicine to relax while on the breathing machine.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Your baby was born before 32 weeks of pregnancy.
- Your baby is currently younger than 45 weeks corrected age (counting from conception).
- Your baby needs medicine to relax while on a breathing tube (ventilator) in the NICU.
- Your baby has not received dexmedetomidine or midazolam in the last 48 hours (except for the procedure to insert the breathing tube).
- Your baby has a working IV line or a plan to place one.
- Both parents must sign a consent form.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a medication called dexmedetomidine to help keep premature babies calm and comfortable while on a breathing machine. It may reduce the need for stronger sedatives and improve recovery.
This study tests whether a sedative medication called dexmedetomidine can reduce confusion and delirium in children who need mechanical ventilation (breathing machines) in the intensive care unit. Researchers want to see if it works better and safer than standard sedatives.
This early-phase trial compares two calming medicines to help critically ill, agitated patients come off the breathing machine earlier and more safely. Your participation would help doctors learn which medicine works better for agitation during the weaning process.
This study tests a “goal-directed” approach to sedation (giving the right amount based on target goals) for children who need a breathing machine in the pediatric ICU. The goal is to reduce brain and recovery side effects while keeping children comfortable and safe.
This study tests two different doses of the sedative midazolam, along with another medicine called dexmedetomidine, to help children relax before surgery. It aims to find the safest and most effective dose for kids having short, planned procedures.
This study measures how morphine works in very young babies, and whether adding midazolam changes how the medicines behave and affect the body. It may help doctors better choose and dose pain/sedation medicines for babies in intensive care.
Hear when a new PreTerm Neonate trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.